Literature DB >> 15665085

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.

Chiara Buono1, Christoph J Binder, George Stavrakis, Joseph L Witztum, Laurie H Glimcher, Andrew H Lichtman.   

Abstract

The influence of the immune system on atherosclerosis involves both helper T (Th) cell and antibody responses to plaque antigens. These responses may have proatherogenic and protective effects. T-bet is a transcription factor required for Th1 differentiation and regulates the balance between Th1 and Th2 responses in inflammatory diseases. To clarify how helper T cell subset differentiation influences atherosclerosis, we compared lesion development and immune responses to plaque antigens in low-density lipoprotein receptor-deficient (Ldlr-/-) mice with or without functional T-bet genes. Atherosclerosis was significantly reduced in T-bet-deficient Ldlr-/- mice compared with Ldlr-/- controls, and the lesions that did develop in the absence of T-bet had less smooth muscle cell content. Furthermore, T-bet deficiency caused a Th2 switch in the response to the atherosclerosis-associated antigen heat shock protein-60, and a change in T-dependent isotypes of oxidized LDL-specific antibodies. Of particular significance, T-bet deficiency caused a >250% increase in the titer of E06 antibodies, which are known to be atheroprotective and whose production by B-1 B cells is enhanced by IL-5. These findings establish that T cell subset differentiation influences both T cell and antibody responses that modulate atherosclerosis, and validate the therapeutic goal of skewing T responses to atherosclerosis-associated antigens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665085      PMCID: PMC547865          DOI: 10.1073/pnas.0409015102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

2.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

3.  Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.

Authors:  X Zhou; S Stemme; G K Hansson
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

4.  Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice.

Authors:  G Caligiuri; A Nicoletti; X Zhou; I Törnberg; G K Hansson
Journal:  Atherosclerosis       Date:  1999-08       Impact factor: 5.162

5.  Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits.

Authors:  G K Hansson; P S Seifert; G Olsson; G Bondjers
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

6.  T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1.

Authors:  S Stemme; J Holm; G K Hansson
Journal:  Arterioscler Thromb       Date:  1992-02

Review 7.  Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis.

Authors:  Chiara Buono; Andrew H Lichtman
Journal:  Trends Cardiovasc Med       Date:  2004-05       Impact factor: 6.677

8.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

Authors:  S Ishibashi; M S Brown; J L Goldstein; R D Gerard; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.

Authors:  S Stemme; B Faber; J Holm; O Wiklund; J L Witztum; G K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

Review 10.  Autoimmune and inflammatory mechanisms in atherosclerosis.

Authors:  Georg Wick; Michael Knoflach; Qingbo Xu
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  125 in total

Review 1.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

Review 2.  microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis.

Authors:  Martin Busch; Alma Zernecke
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

3.  Identifying genetic loci and spleen gene coexpression networks underlying immunophenotypes in BXD recombinant inbred mice.

Authors:  Rachel M Lynch; Sudhir Naswa; Gary L Rogers; Stephen A Kania; Suchita Das; Elissa J Chesler; Arnold M Saxton; Michael A Langston; Brynn H Voy
Journal:  Physiol Genomics       Date:  2010-02-23       Impact factor: 3.107

Review 4.  Atherosclerosis: current pathogenesis and therapeutic options.

Authors:  Christian Weber; Heidi Noels
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

5.  Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.

Authors:  John Hallenbeck; Gregory Del Zoppo; Tom Jacobs; Antoine Hakim; Stephen Goldman; Ursula Utz; Ahmed Hasan
Journal:  Stroke       Date:  2006-11-02       Impact factor: 7.914

Review 6.  The role of adaptive T cell immunity in atherosclerosis.

Authors:  Ziad Mallat; Soraya Taleb; Hafid Ait-Oufella; Alain Tedgui
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

7.  STAT4 deficiency reduces the development of atherosclerosis in mice.

Authors:  Parésa L Taghavie-Moghadam; Breanne N Gjurich; Rukhsana Jabeen; Purna Krishnamurthy; Mark H Kaplan; Anca D Dobrian; Jerry L Nadler; Elena V Galkina
Journal:  Atherosclerosis       Date:  2015-09-04       Impact factor: 5.162

8.  Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.

Authors:  Joseph J Boyle; Heather A Harrington; Emma Piper; Kay Elderfield; Jaroslav Stark; Robert C Landis; Dorian O Haskard
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

9.  Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

Authors:  Manikandan Subramanian; Edward Thorp; Goran K Hansson; Ira Tabas
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

Review 10.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.